Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 140th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
TGTX	TG THERAPEUTICS INC	$6.56B	87.40%	42.80%	11.17%	13.50%	1.62	5.81	83.10%	66.00%	21.41%
ENLV	ENLIVEX LTD	$182.78M	248.10%	206.40%	69.81%	279.90%	0.20	193.24	N/A	N/A	N/A
DMRA	DAMORA THERAPEUTICS INC	$1.46B	-307.40%	-279.50%	-87.24%	6,125.20%	0.08	12.98	N/A	N/A	N/A
BCRX	BIOCRYST PHARMACEUTICALS INC	$2.19B	N/A	-97.30%	-140.55%	-44.00%	-1.84	1.91	97.80%	-51.70%	-42.79%
NBTX	NANOBIOTIX SA	$2.20B	N/A	-35.50%	-85.10%	-27.90%	-1.80	1.09	100.00%	-73.50%	-26.77%
HYPD	HYPERION DEFI INC	$41.01M	-134.80%	-95.80%	-89.18%	-100.30%	0.26	2.68	62.70%	-5,777.70%	-5,379.11%
LBRX	LB PHARMACEUTICALS INC	$916.73M	-24.40%	-14.50%	-8.25%	-79.00%	0.04	41.45	N/A	N/A	N/A
WVE	WAVE LIFE SCIENCES LTD	$1.38B	-56.80%	-42.80%	-34.40%	931.70%	0.14	11.26	100.00%	-255.70%	-255.70%
PGEN	PRECIGEN INC	$1.49B	-14,393.40%	-308.30%	-208.78%	-195.80%	6.44	3.09	50.20%	-4,436.60%	-2,548.24%
AVTX	AVALO THERAPEUTICS INC	$491.55M	-77.90%	-61.80%	-75.44%	-143.00%	0.40	8.14	100.00%	-132,642.40%	-132,362.71%
AGIO	AGIOS PHARMACEUTICALS INC	$1.65B	-34.10%	-31.70%	-37.62%	-35.00%	0.07	14.19	90.00%	-639.80%	-641.38%
CTXR	CITIUS PHARMACEUTICALS INC	$14.32M	-52.50%	-27.60%	-33.67%	-48.00%	0.59	0.99	80.00%	-909.90%	-872.34%
SLS	SELLAS LIFE SCIENCES GROUP INC	$899.71M	-63.10%	-54.50%	-37.66%	3,232.60%	0.11	10.72	N/A	N/A	N/A
CDXS	CODEXIS INC	$259.06M	-68.10%	-23.70%	-23.36%	-18.10%	1.99	5.36	88.90%	-41.00%	-34.26%
PYXS	PYXIS ONCOLOGY INC	$172.16M	-101.80%	-69.80%	-111.15%	-78.30%	0.71	3.41	82.80%	-574.50%	-564.55%
DNTH	DIANTHUS THERAPEUTICS INC	$4.74B	-27.30%	-25.90%	-14.37%	-38.00%	0.04	29.25	100.00%	-12,998.50%	-12,998.50%
ALXO	ALX ONCOLOGY HOLDINGS INC	$273.75M	-182.00%	-113.60%	-290.18%	-175.40%	1.27	2.07	N/A	N/A	N/A
SNDX	SYNDAX PHARMACEUTICALS INC	$1.90B	-256.70%	-45.20%	-53.21%	-31.60%	10.36	5.47	96.00%	-111.90%	-94.59%
PHAT	PHATHOM PHARMACEUTICALS INC	$969.83M	N/A	-59.70%	-50.79%	-16.70%	-1.91	2.21	84.90%	-76.80%	-44.64%
ABCL	ABCELLERA BIOLOGICS INC	$1.59B	-14.80%	-10.70%	-13.74%	-15.00%	0.40	11.32	100.00%	-194.90%	-236.39%
RAPP	RAPPORT THERAPEUTICS INC	$1.82B	-24.80%	-23.40%	-22.36%	-31.20%	0.06	27.08	100.00%	-536.40%	-536.39%
MRNA	MODERNA INC	$21.57B	-36.70%	-26.60%	-34.51%	-33.60%	0.55	2.41	22.10%	-143.60%	-141.03%
RIGL	RIGEL PHARMACEUTICALS INC	$481.79M	147.00%	99.30%	31.05%	49.00%	0.26	2.62	93.40%	121.50%	42.99%
CAMP	CAMP4 THERAPEUTICS CORP	$231.59M	-194.70%	-95.60%	-97.15%	-12,049.00%	2.41	6.15	100.00%	-2,193.70%	-2,193.72%
AXSM	AXSOME THERAPEUTICS INC	$11.19B	-260.00%	-27.80%	-66.88%	-125.30%	12.07	1.39	92.60%	-26.60%	-25.91%
RLMD	RELMADA THERAPEUTICS INC	$767.80M	-170.80%	-145.60%	-65.53%	-178.90%	0.09	14.62	N/A	N/A	N/A
QTTB	Q32 BIO INC	$91.06M	230.70%	53.30%	62.72%	217.40%	0.38	5.36	100.00%	61.90%	61.86%
CYTK	CYTOKINETICS INC	$9.57B	N/A	-61.90%	-72.46%	-35.50%	-2.54	4.21	97.60%	-784.00%	-735.60%
COAG	HEMAB THERAPEUTICS HOLDINGS INC	N/A	N/A	N/A	-34.84%	N/A	-0.06	18.03	N/A	N/A	N/A
EVMN	EVOMMUNE INC	$825.54M	N/A	N/A	N/A	N/A	0.06	20.36	N/A	N/A	N/A
SGMT	SAGIMET BIOSCIENCES INC	$251.23M	-40.80%	-38.60%	-45.82%	-62.70%	0.05	22.82	N/A	N/A	N/A
QURE	UNIQURE NV	$1.74B	-145.80%	-27.20%	-19.78%	-16.30%	4.21	10.40	90.60%	-1,154.40%	-786.66%
VOR	VOR BIOPHARMA INC	$827.48M	N/A	-291.50%	-158.55%	-3,997.20%	-3.83	18.20	N/A	N/A	N/A
SRZN	SURROZEN INC	$336.24M	N/A	-346.50%	-324.35%	-3,450.40%	-1.43	11.91	100.00%	-4,810.50%	-4,810.50%
ZYME	ZYMEWORKS INC	$1.74B	-37.80%	-25.20%	-23.03%	-31.60%	1.92	10.82	100.00%	-126.30%	-125.40%
GALT	GALECTIN THERAPEUTICS INC	$138.24M	N/A	-215.40%	-204.37%	-41.70%	-1.14	2.42	N/A	N/A	N/A
AURA	AURA BIOSCIENCES INC	$538.86M	-71.20%	-59.10%	-70.23%	-90.10%	0.24	8.15	N/A	N/A	N/A
KLRA	KAILERA THERAPEUTICS INC	N/A	N/A	N/A	-23.06%	N/A	-0.16	12.02	N/A	N/A	N/A
AGMB	AGOMAB THERAPEUTICS NV	$591.18M	-39.20%	-34.70%	-46.19%	-629.60%	0.17	6.52	N/A	N/A	N/A
ACAD	ACADIA PHARMACEUTICALS INC	$3.84B	35.60%	26.20%	8.86%	14.50%	0.29	3.59	91.50%	34.30%	10.51%
AVLN	AVALYN PHARMA INC	N/A	N/A	N/A	-63.21%	N/A	-0.06	10.19	N/A	N/A	N/A
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$129.74M	N/A	-1,355.70%	346.41%	522.20%	-1.16	0.07	100.00%	-155,404.40%	-149,141.39%
TPST	TEMPEST THERAPEUTICS INC	$28.54M	-309.60%	-115.80%	-191.34%	-204.90%	1.54	2.50	N/A	N/A	N/A
BCAB	BIOATLA INC	$8.02M	N/A	-250.60%	736.43%	977.80%	-1.38	0.37	100.00%	-2,980.30%	-2,980.35%
AVXL	ANAVEX LIFE SCIENCES CORP	$298.40M	-38.80%	-35.00%	-31.54%	408.90%	0.05	20.87	N/A	N/A	N/A
FATE	FATE THERAPEUTICS INC	$277.87M	-55.00%	-38.10%	-48.19%	-38.40%	0.54	5.79	100.00%	-2,051.10%	-2,051.08%
KPTI	KARYOPHARM THERAPEUTICS INC	$158.49M	N/A	-179.30%	-917.99%	-86.00%	-1.37	1.12	95.90%	-134.20%	-102.79%
TLX	TELIX PHARMACEUTICALS LTD	$3.62B	-1.40%	-0.50%	3.82%	5.50%	1.80	1.43	53.10%	-0.90%	4.43%
IVVD	INVIVYD INC	$423.89M	-48.70%	-34.50%	-21.63%	-414.90%	0.15	7.24	93.00%	-98.20%	-98.25%
CRDF	CARDIFF ONCOLOGY INC	$112.12M	-82.00%	-64.10%	-100.79%	-109.80%	0.36	3.67	100.00%	-7,736.30%	-7,732.04%
BLTE	BELITE BIO INC	$6.09B	-16.90%	-16.60%	-10.07%	-29.10%	0.01	50.02	N/A	N/A	N/A
MDGL	MADRIGAL PHARMACEUTICALS INC	$11.76B	-50.20%	-25.40%	-31.79%	-29.40%	1.26	3.50	93.10%	-27.30%	-24.95%
NXTC	NEXTCURE INC	$35.25M	-190.20%	-124.60%	-175.85%	-218.70%	0.42	4.61	N/A	N/A	N/A
RNA	ATRIUM THERAPEUTICS INC	N/A	N/A	-637.10%	148.42%	233.10%	-1.13	0.07	100.00%	-265.90%	-266.64%
ERAS	ERASCA INC	$3.15B	-34.50%	-28.70%	-33.88%	-32.40%	0.22	10.04	N/A	N/A	N/A
XFOR	X4 PHARMACEUTICALS INC	$417.84M	-94.90%	-48.10%	-36.88%	-92.30%	0.61	10.18	81.80%	-1,106.30%	-1,008.50%
SION	SIONNA THERAPEUTICS INC	$1.99B	-22.90%	-21.70%	-23.95%	-26.20%	0.06	20.61	N/A	N/A	N/A
HYFT	MINDWALK HOLDINGS CORP	$59.32M	-63.70%	-36.50%	-67.58%	-72.80%	0.55	3.74	60.30%	-66.50%	-65.87%
LYEL	LYELL IMMUNOPHARMA INC	$451.05M	-85.70%	-66.40%	-78.55%	-87.90%	0.28	7.24	100.00%	-849,675.90%	-849,675.86%
ONCY	ONCOLYTICS BIOTECH INC	$103.35M	-2,127.50%	-243.40%	-1,936.53%	1,727.10%	-3.00	1.12	N/A	N/A	N/A
GMAB	GENMAB A	$16.98B	14.50%	8.50%	12.60%	34.20%	1.18	2.18	93.30%	21.00%	36.17%
CRIS	CURIS INC	$22.43M	N/A	-26.10%	-128.73%	103.70%	2.66	0.49	99.50%	-80.30%	-80.29%
ZSQR	Z SQUARED INC	$77.57M	-130.60%	-85.20%	-82.17%	-176.80%	0.15	4.16	86.70%	-874.30%	-867.20%
LXRX	LEXICON PHARMACEUTICALS INC	$888.39M	-18.60%	-11.80%	-6.95%	-12.50%	0.33	18.80	99.50%	-37.50%	-25.84%
VSTM	VERASTEM INC	$429.70M	-486.40%	-91.60%	-119.67%	-371.70%	1.79	3.04	83.20%	-391.20%	-388.49%
ADCT	ADC THERAPEUTICS SA	$445.17M	N/A	-44.70%	-37.69%	-77.60%	-2.35	4.09	90.70%	-173.00%	-106.58%
PDSB	PDS BIOTECHNOLOGY CORP	$69.77M	-242.00%	-90.40%	-150.13%	-264.40%	2.30	2.98	N/A	N/A	N/A
ROIV	ROIVANT SCIENCES LTD	$20.44B	-18.30%	-15.60%	-14.29%	-20.80%	0.06	30.66	91.20%	-6,079.90%	-5,446.60%
NVCT	NUVECTIS PHARMA INC	$309.02M	-161.00%	-98.90%	-191.00%	238.90%	0.79	2.27	N/A	N/A	N/A
ORKA	ORUKA THERAPEUTICS INC	$3.20B	-25.30%	-24.30%	-22.28%	-30.30%	0.04	22.37	N/A	N/A	N/A
GRDX	GRIDAI TECHNOLOGIES CORP	$21.20M	-82.80%	-7.20%	-18.87%	-16.70%	1.00	0.17	-1,813.60%	-17,634.40%	-17,380.36%
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$10.97M	-959.90%	-162.30%	-229.34%	232.20%	0.84	2.08	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$651.05M	-31.50%	-30.40%	-35.60%	-36.30%	0.03	27.86	N/A	N/A	N/A
NAUT	NAUTILUS BIOTECHNOLOGY INC	$340.57M	-35.00%	-29.20%	-33.69%	-29.30%	0.23	11.85	N/A	N/A	N/A
CRBU	CARIBOU BIOSCIENCES INC	$192.41M	-100.10%	-72.00%	-103.44%	-78.30%	0.46	6.22	100.00%	-1,512.80%	-1,519.07%
DBVT	DBV TECHNOLOGIES SA	$1.17B	-129.90%	-88.80%	-77.72%	2,867.80%	0.28	4.76	100.00%	-2,895.40%	-2,883.42%
CHRS	COHERUS ONCOLOGY INC	$262.31M	789.40%	42.40%	150.08%	287.40%	3.23	1.47	67.20%	398.40%	419.77%
CGTX	COGNITION THERAPEUTICS INC	$108.12M	-104.30%	-69.60%	-68.11%	770.80%	0.41	3.45	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$888.14M	-33.10%	-31.30%	-31.65%	-35.40%	0.06	22.28	N/A	N/A	N/A
EDSA	EDESA BIOTECH INC	$136.08M	-55.80%	-52.50%	-56.01%	3,171.80%	0.05	16.82	N/A	N/A	N/A
IMRX	IMMUNEERING CORP	$337.49M	-43.30%	-39.70%	-25.25%	-222.20%	0.06	17.50	N/A	N/A	N/A
NTLA	INTELLIA THERAPEUTICS INC	$1.66B	-56.60%	-45.20%	-55.90%	-54.50%	0.25	5.08	100.00%	-609.90%	-609.85%
GPCR	STRUCTURE THERAPEUTICS INC	$2.78B	-15.10%	-14.40%	-11.70%	-21.30%	0.04	26.16	N/A	N/A	N/A
PYPD	POLYPID LTD	$79.73M	-366.30%	-143.80%	-229.81%	-391.20%	1.03	1.97	N/A	N/A	N/A
ICU	SEASTAR MEDICAL HOLDING CORP	$17.93M	-188.50%	-106.40%	-116.32%	454.30%	0.36	3.63	95.70%	-984.60%	-981.85%
ZLAB	ZAI LAB LTD	$2.09B	-24.30%	-15.50%	-24.75%	-138.50%	0.66	2.40	57.90%	-39.30%	-38.37%
LABT	LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC	N/A	N/A	-495.80%	194.79%	2,218.00%	-1.25	0.13	N/A	N/A	N/A
IOVA	IOVANCE BIOTHERAPEUTICS INC	$1.62B	-50.20%	-38.80%	-44.55%	-92.90%	0.28	3.61	36.70%	-123.90%	-124.21%
STRO	SUTRO BIOPHARMA INC	$666.67M	N/A	-79.00%	-197.61%	-200.30%	-2.31	2.01	100.00%	-186.50%	-190.31%
FRMM	FORUM MARKETS INC	$93.64M	-258.30%	-134.70%	-168.62%	-143.30%	0.28	0.33	100.00%	-6,881.30%	-6,834.66%
INO	INOVIO PHARMACEUTICALS INC	$100.87M	-353.40%	-113.60%	-277.23%	-1,484.30%	2.08	1.40	100.00%	-130,000.00%	-130,000.00%
CORT	CORCEPT THERAPEUTICS INC	$5.61B	7.30%	5.70%	-1.34%	-1.60%	0.28	2.86	98.30%	6.10%	-1.16%
RYTM	RHYTHM PHARMACEUTICALS INC	$6.45B	-208.40%	-46.10%	-53.66%	-69.50%	1.67	4.17	89.40%	-95.70%	-83.79%
IBRX	IMMUNITYBIO INC	$8.91B	N/A	-165.20%	-128.27%	-60.00%	-1.74	6.67	99.30%	-606.20%	-526.54%
CTNM	CONTINEUM THERAPEUTICS INC	$543.22M	-27.10%	-25.60%	-22.95%	-31.20%	0.05	38.00	N/A	N/A	N/A
PRQR	PROQR THERAPEUTICS NV	$166.47M	-66.90%	-32.10%	-50.90%	-1,891.60%	1.28	3.09	100.00%	-258.10%	-250.06%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$10.24B	-55.40%	-18.10%	-9.57%	-9.10%	2.72	6.23	100.00%	-48.40%	-30.37%
ACTU	ACTUATE THERAPEUTICS INC	$78.24M	-799.60%	-205.80%	-266.63%	320.70%	0.77	2.39	N/A	N/A	N/A
EQ	EQUILLIUM INC	$133.41M	-119.20%	-93.80%	-77.36%	805.80%	0.12	10.58	N/A	N/A	N/A
CRMD	CORMEDIX INC	$626.08M	58.50%	33.00%	23.44%	91.90%	1.04	2.11	88.50%	52.30%	49.02%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #1 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 27, which is 2 points higher than the biotech industry average of 25.

JAZZ passed 9 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 129.44% over the past year, overperforming other biotech stocks by 132 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $237.67, an upside of 5.26% from Jazz Pharmaceuticals's current stock price of $225.79.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Jazz Pharmaceuticals, 58.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 8.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the #2 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: B.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 52, which is 27 points higher than the biotech industry average of 25.

EXEL passed 17 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 31.95% over the past year, overperforming other biotech stocks by 34 percentage points.

Exelixis has an average 1 year price target of $48.00, a downside of -0.33% from Exelixis's current stock price of $48.16.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Exelixis, 14.29% have issued a Strong Buy rating, 14.29% have issued a Buy, 71.43% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #3 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 56, which is 31 points higher than the biotech industry average of 25.

PBYI passed 18 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 143.97% over the past year, overperforming other biotech stocks by 146 percentage points.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 18.27%, which is 14 percentage points higher than the biotech industry average of 4.3%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 6.11%, which is 2 percentage points higher than the biotech industry average of 4.3%.

Oramed Pharmaceuticals's dividend payout ratio of 16.3% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.77%, which is -2 percentage points lower than the biotech industry average of 4.3%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 43.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.17% in the last day, and up 2.15% over the last week. Traws Pharma was the among the top gainers in the biotechnology industry, gaining 28.24% yesterday.

Traws Pharma shares are trading higher after the company announced plans to advance potential clinical candidates for the treatment of hantavirus infections.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Rigel Pharmaceuticals has a valuation score of 43, which is 30 points higher than the biotech industry average of 13. It passed 3 out of 7 valuation due diligence checks.

Rigel Pharmaceuticals's stock has gained 37.78% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Incyte's stock has gained 65.01% in the past year. It has overperformed other stocks in the biotech industry by 67 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -9.09% in the past year. It has underperformed other stocks in the biotech industry by -7 percentage points.

Are biotech stocks a good buy now?

65.08% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 61.11% over the next year.

3.09% of biotech stocks have a Zen Rating of A (Strong Buy), 3.75% of biotech stocks are rated B (Buy), 47.46% are rated C (Hold), 34.44% are rated D (Sell), and 11.26% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.13x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Exelixis (NASDAQ:EXEL)

3. Puma Biotechnology (NASDAQ:PBYI)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

2. Incyte (NASDAQ:INCY)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Exelixis (NASDAQ:EXEL)

3. Puma Biotechnology (NASDAQ:PBYI)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

2. Incyte (NASDAQ:INCY)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.